Patent · US Active

Anti-Siglec-15 antibodies and uses thereof

US9994636B2 · kind B2 · utility

1Cited by
1References
11Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 9, 2016
Grant dateJun 12, 2018
Priority date—
Expiry dateAug 9, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/77
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

This disclosure relates to anti-Siglec-15 antibodies and uses thereof, in particular in the treatment of leukaemia, such as acute myeloid leukaemia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.